Delivery Order SPE2DB24D1201-SPE2DB24FJBAF

Award Date 8/19/24
Potential Completion Date 8/20/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,939.11 firm fixed-price delivery order is for the supply of Letrozole 2.5 mg tablets with a completion date of November 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Letrozole 2.5 mg tablets. The contract has a total ceiling value of $1,395.83 and a period of performance through June 10, 2025. This is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,048.80 firm-fixed-price contract is for the supply of 90-count bottles of the drug Letrozole 2.5 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of...
This federal contract award, valued at $1,387.11, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Letrozole 2.5 mg tablets to the government. This delivery order contract is a firm fixed-price agreement with an ultimate completion date of April 21, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,045.56 firm fixed-price delivery order is for the supply of Letrozole 2.5 mg tablets, with an ultimate completion date of November 5, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Letrozole 2.5 mg tablets to the Defense Logistics Agency (DLA). The $9,097.28 firm fixed-price delivery order has a completion date of February 27, 2025. The contract is not designated as a set-aside and is issued under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,688.02 firm fixed-price delivery order is for the supply of 90-tablet bottles of the drug Letrozole 2.5 mg. The contract has a ceiling value of $9,688.02 and an ultimate completion date of May 21, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 90-count tablets of the drug Letrozole 2.5 mg, with a firm fixed price of $1,081.74 and a completion date of July 3, 2025. The contract is not set aside and was competed openly. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award, valued at $1,336.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Letrozole 2.5 mg tablets, a medication used in the treatment of certain medical conditions. The contract is a delivery order with a firm fixed price, and it does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,800.88, is for the delivery of Letrozole 2.5 mg tablets in 30-count packages. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB24D1201
    Indefinite Delivery Contract
  • SPE2DB24D1201-SPE2DB24FJBAF
    Delivery Order

This is a delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of 4,565,505,353 units of Letrozole 2.5 mg tablets. The firm-fixed price contract has a ceiling value of $1,045.56 and an ultimate completion date of August 20, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, such as the Department of Justice Federal Bureau of Investigation, for the provision of a wide range of pharmaceuticals and medical supplies to support military treatment facilities, veterans' healthcare, and other government healthcare programs nationwide.

Generated 11/18/24, 9:25 AM